Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and afliberceptOA
Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept
Jia-Kang Wang;Tzu-Lun Huang;Pei-Yuan Su;Pei-Yao Chang
Department of Ophthalmology, Far Eastern Memorial Hospital, New Taipei, Taiwan, ChinaDepartment of Medicine, National Yang Ming University, Taipei, Taiwan, ChinaDepartment of Healthcare Administration,Oriental Institute of Technology, New Taipei, Taiwan, ChinaDepartment of Nursing, Oriental Institute of Technology, New Taipei, Taiwan, China
Intravitreal injectionafliberceptranibizumabmyopic choroidal neovascularization (mCNV)
Intravitreal injectionafliberceptranibizumabmyopic choroidal neovascularization (mCNV)
《眼科学报(英文版)》 2015 (4)
198-200,3
评论